Lv31
300 积分 2025-06-06 加入
Key Considerations in the Transition to Risk-Based Monitoring
2小时前
已完结
Adoption Maturity Model for Risk-based Quality Management (RBQM) in Clinical Trials
2小时前
已完结
Risk-Based Quality Management: Who Should Be in the Room and When While Assessing Risks During a Clinical Trial?
4小时前
待确认
Risk-Based Quality and Compliance Management in Clinical Trials with Combination Products in Changing Global Regulatory Environment
4小时前
已完结
Risk-based safety and quality management strategies in wound care trials at a tertiary, safety net hospital
4小时前
待确认
Six Sigma Quality Management System and Design of Risk-based Statistical Quality Control
5小时前
已完结
Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model
5小时前
已完结
HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis
16天前
已完结
HER3: Updates and current biology function, targeted therapy and pathologic detecting methods
16天前
已完结
ERBB receptors and cancer: the complexity of targeted inhibitors
18天前
已完结
皖公网安备34019202002308